Pulmonary Thromboembolism in Dogs: PTE Diagnosis and Treatment

Last updated: May 16, 2026

What Pulmonary Thromboembolism Is

Pulmonary thromboembolism (PTE) in dogs is the sudden lodging of a blood clot in the pulmonary arteries — the vessels that carry blood from the right side of the heart through the lungs for oxygenation. The clot blocks blood flow to part of the lung, oxygen exchange in that region drops sharply, and the dog presents with abrupt severe respiratory distress. The right side of the heart suddenly works against an increased resistance, and circulatory shock can follow.

PTE is almost always a complication of an underlying disease rather than a primary problem. The dog’s blood becomes hypercoagulable — more prone to clotting than normal — because of an underlying condition such as immune-mediated hemolytic anemia, hyperadrenocorticism, protein-losing nephropathy, neoplasia, sepsis, or pancreatitis. Once the prothrombotic state exists, a clot forms somewhere in the venous system, breaks loose, and travels through the right heart into the pulmonary arteries.

If your vet has just told you your dog has PTE, you are facing a true emergency. The next several hours of stabilization, oxygen support, and anticoagulant decisions matter enormously. Identifying and treating the underlying disease is equally critical because PTE recurrence is the main long-term concern. The sections below walk through what your team is doing and why.

The Underlying Diseases That Cause PTE

The underlying-disease list is the diagnostic engine in PTE. A dog who develops sudden severe respiratory distress without trauma, without a heart murmur, and without obvious cardiac decompensation should always be worked up for PTE — and the workup includes a hunt for the underlying prothrombotic condition.

Major underlying causes in dogs include:

• Immune-mediated hemolytic anemia (IMHA) — perhaps the most classic association; PTE is a major cause of IMHA mortality
• Immune-mediated thrombocytopenia (ITP) — particularly in combination with IMHA (Evans syndrome)
• Hyperadrenocorticism — Cushing’s disease creates a hypercoagulable state
• Protein-losing nephropathy with nephrotic syndrome — antithrombin loss in urine drives clotting
• Protein-losing enteropathy from intestinal lymphangiectasia and similar conditions
• Neoplasia — particularly cancer with paraneoplastic hypercoagulability
• Sepsis and systemic inflammatory response
• Acute and chronic pancreatitis
• Heartworm disease
• Cardiac disease with atrial enlargement
• Recent surgery or trauma with prolonged immobility

The list is long, and each condition has its own management trajectory. ACVIM internal medicine specialists are central to the workup because identifying the right underlying disease and treating it is the only way to reduce future PTE risk.

Symptoms Owners Notice First

The presentation is sudden and dramatic. A dog who was bright, eating, and active that morning develops abrupt severe respiratory distress over minutes to hours. Many dogs with PTE have a known underlying disease and are already being managed — IMHA on immunosuppression, Cushing’s on trilostane — and the new PTE event marks a sudden change from a stable disease course.

Watch for these red flags that warrant an immediate emergency vet visit:

• Sudden severe rapid breathing or panting in a dog without obvious trigger
• Stretched-out posture with elbows held away from the body
• Pale, blue, or grey gums
• Collapse, weakness, or unresponsiveness
• Fainting episodes (syncope)
• Cough — sometimes with blood-tinged sputum
• Rapid heart rate
• Sudden lethargy in a dog with known IMHA, Cushing’s, nephrotic syndrome, or cancer

Time matters enormously. A dog with sudden severe respiratory distress on a background of known prothrombotic disease should go to the emergency hospital immediately, not the next day. ACVECC-trained critical care teams handle these cases efficiently when minutes count, and stabilization with oxygen and supportive care can be the difference between recovery and a much harder outcome.

How Your Vet Will Diagnose It

PTE is one of the harder respiratory diagnoses to confirm, because no single bedside test definitively proves the clot exists. Diagnosis is built from a combination of clinical picture, imaging, biomarkers, and exclusion of other causes of acute respiratory distress.

A typical workup includes:

• Pulse oximetry and arterial blood gas — typically show severe hypoxemia with a wide alveolar-arterial oxygen gradient
• Chest radiographs — often surprisingly unremarkable in PTE; sometimes show focal hyperlucency, pleural effusion, or pulmonary infiltrates
• Bedside ultrasound (TFAST/POCUS) — assesses for pleural fluid, pulmonary edema, or right-sided cardiac strain
• Echocardiogram — looks for right ventricular dilation, septal flattening, and tricuspid regurgitation that suggest acute pulmonary hypertension
• D-dimer — elevated in active clotting, useful as a screening tool but not definitive
• CT pulmonary angiography (CTA) — the imaging gold standard; visualizes filling defects in the pulmonary arteries directly
• Complete blood count, biochemistry, urinalysis, coagulation profile
• Workup for underlying cause — Coombs test, ACTH stimulation, urine protein:creatinine ratio, abdominal imaging

CTA is the most direct diagnostic test, but the dog must be stable enough to lie still for the scan. In an unstable patient, PTE is often a clinical diagnosis based on the right combination of risk factor, presentation, and supportive findings, with empiric anticoagulant therapy started before the CTA confirms it.

Emergency Stabilization

The first priority is oxygen and gentle handling. A dog in respiratory distress is placed in oxygen, restraint is minimized, and stress is reduced as much as possible. Sedation with butorphanol or another low-dose opioid sometimes helps reduce respiratory effort and oxygen demand.

Other initial therapies often include:

• IV fluids with caution — too much can worsen pulmonary edema in a stressed right heart
• Anticoagulation — heparin (unfractionated or low-molecular-weight) is the typical immediate choice
• Antiarrhythmics if needed
• Bronchodilators in selected cases
• Treatment of any concurrent decompensation of the underlying disease

Specific anticoagulant doses are vet-determined based on weight, kidney function, hemorrhage risk, and ongoing bleeding parameters — there is no one-size-fits-all protocol. The decision to anticoagulate a dog who already has IMHA or another bleeding-prone underlying disease requires careful balance, and ACVECC critical care training is central to managing this trade-off well.

Anticoagulant Therapy

Anticoagulation is the cornerstone of PTE treatment. The goal is to prevent further clot formation while the body’s own fibrinolytic system breaks down the existing clot. Thrombolytic therapy (clot-busting drugs) is rarely used in dogs because of the bleeding risk and limited evidence.

Common anticoagulant approaches include:

• Unfractionated heparin — IV in the hospital, with frequent coagulation monitoring
• Low-molecular-weight heparin (enoxaparin, dalteparin) — subcutaneous, more predictable dosing
• Direct oral anticoagulants (rivaroxaban, apixaban) — increasingly used long-term once stable
• Antiplatelet agents (clopidogrel, low-dose aspirin) — sometimes added or used long-term in lower-risk situations

The duration of anticoagulation depends on whether the underlying cause can be controlled. A dog with controllable IMHA may need anticoagulation for several months. A dog with ongoing prothrombotic disease (active cancer, persistent nephrotic syndrome) may need lifelong anticoagulation. Each plan is individualized.

Treating the Underlying Disease

The most important long-term intervention is addressing the underlying prothrombotic condition. Without that, PTE recurs and the prognosis worsens significantly. Specific treatment depends on the diagnosis:

• IMHA — immunosuppression with corticosteroids, sometimes adjunct agents like cyclosporine or mycophenolate
• Cushing’s disease — trilostane or, in selected cases, mitotane; surgery for adrenal tumors
• Nephrotic syndrome — ACE inhibitors, dietary modification, addressing the underlying glomerular disease
• Protein-losing enteropathy — dietary therapy, immunosuppression, treating intestinal lymphangiectasia
• Cancer — surgery, chemotherapy, or palliative care depending on type and stage
• Pancreatitis — supportive care, dietary changes, addressing underlying triggers
• Sepsis — source control, antibiotics, supportive care

This is why a multi-specialty team often manages PTE cases. ACVIM internal medicine guides the underlying disease workup; ACVECC critical care manages the acute pulmonary event; ACVIM-Cardiology assists when right-heart strain is significant. The coordination matters because PTE is rarely a single-organ-system problem.

Hospital Course and What to Expect

Most dogs with PTE require several days of hospitalization. The initial 24 to 48 hours are the most critical — oxygen support, anticoagulation, and stabilization of the underlying disease all happen simultaneously. Once respiratory rate is stable on room air or low-flow oxygen and underlying disease is being managed, transition to oral medications and discharge planning begins.

Discharge instructions typically include:

• Oral anticoagulant medication on a strict schedule
• Continued therapy for the underlying disease
• Restricted activity for one to two weeks — leash walks only
• Resting respiratory rate counts twice daily
• Watch for any sign of bleeding (hematuria, melena, gum bleeding, easy bruising)
• Recheck appointments at one and two weeks, then as planned
• Follow-up imaging if clinically warranted

Most dogs who survive the acute event recover well in the short term, but the long-term outlook depends almost entirely on whether the underlying disease can be controlled. A well-managed Cushing’s dog or a remission-stage IMHA dog may go years without another PTE event. A dog with metastatic cancer or refractory underlying disease has a more guarded outlook.

Recurrence Risk and Long-Term Management

Recurrence is the central long-term concern. Dogs who have had one PTE event and have an ongoing underlying prothrombotic disease have a meaningfully increased risk of a second event. This is why long-term anticoagulation is often recommended — sometimes for months, sometimes for life — and why aggressive control of the underlying disease matters so much.

Resting respiratory rate at home is the single most useful monitoring metric. Count breaths per minute while your dog is asleep — chest rise and fall counts as one breath. The goal is under 30. A persistent rise above 40 is a red flag warranting prompt vet evaluation, especially in a dog with known PTE history.

Other things to monitor:

• Energy level and exercise tolerance versus baseline
• Appetite and water intake
• Any sign of bleeding — pink urine, dark tarry stool, gum bleeding, easy bruising
• Compliance with the medication schedule (PTE prevention depends on consistent dosing)
• Body weight

Cost Realities and Insurance

PTE is an expensive disease. Emergency stabilization with oxygen support, CT pulmonary angiography, and several days of inpatient critical care enter four-figure territory quickly. Workup of the underlying disease adds significant cost. Long-term anticoagulant medication is moderate but ongoing. Each subsequent flare or recheck adds up over the disease course.

If your dog is currently healthy and you are considering insurance, look at the pet insurance decision for dogs article. Pre-existing exclusions for any of the underlying prothrombotic diseases are unforgiving — coverage decisions made before any of these conditions are documented are far more useful than after-the-fact applications. Owners already mid-workup should review the veterinary specialist cost breakdown and emergency vet cost realism articles.

For dogs with chronic underlying diseases that drive PTE risk, financial planning matters enormously. Talking through the realistic cost trajectory with your specialist up front, while everyone is calm, is far easier than mid-crisis.

When to Call the Vet Versus the ER

Go to the emergency vet immediately for: sudden severe respiratory distress, blue or grey gums, collapse, sustained respiratory rate above 50, unexplained sudden lethargy in a dog with known IMHA / Cushing’s / nephrotic syndrome / cancer, or any acute change in a dog with known PTE history. PTE is time-critical. Calling first to let the hospital know you are coming is helpful but never delay leaving.

Call your primary vet during business hours for: a stable dog on long-term anticoagulation with a routine recheck question, a small persistent rise in resting respiratory rate, mild lethargy, or any new sign of bleeding (gum bleeding, pink urine, dark stool) that needs prompt attention but is not an immediate emergency.

Print your dog’s medication list, recent imaging summary, and underlying-disease diagnosis on a single sheet, and keep it accessible. If you ever end up at an unfamiliar emergency hospital, that single sheet saves your team valuable minutes during stabilization. Your specialist will provide an emergency contact protocol — keep that number saved in your phone alongside the address of your nearest 24-hour ER.

Frequently Asked Questions

Can a dog survive a pulmonary embolism?

Yes — many dogs with PTE survive the acute event with prompt emergency care, oxygen support, and appropriate anticoagulation. The long-term outlook depends heavily on whether the underlying prothrombotic disease can be controlled. Recurrence is the main long-term risk, which is why long-term anticoagulation and aggressive treatment of the underlying condition are central to management.

How is PTE different from pneumonia or pulmonary edema?

PTE causes sudden severe respiratory distress from a vascular blockage. Pneumonia is an infection of lung tissue, usually progressing over days with fever and cough. Pulmonary edema is fluid leakage into the air spaces, typically cardiogenic. Chest imaging, biomarkers, and the underlying clinical context distinguish them — and treatment is very different for each. The diagnostic workup carefully separates these conditions.

Will my dog be on blood thinners for life?

It depends on whether the underlying condition can be controlled. Dogs with treatable IMHA in remission may need anticoagulation for several months. Dogs with ongoing prothrombotic disease (active cancer, persistent nephrotic syndrome, refractory Cushing’s) may need lifelong anticoagulation. Your specialist will tailor the duration to your dog’s specific situation and ongoing risk.

What does prevention look like for at-risk dogs?

For dogs with known prothrombotic conditions, prevention focuses on tight control of the underlying disease and prophylactic antiplatelet therapy in higher-risk situations. Aspirin and clopidogrel are commonly used. Specific protocols vary by underlying diagnosis and overall risk profile. Discuss with your ACVIM internist whether your dog’s specific condition warrants prophylactic anticoagulation.

Why do dogs with IMHA so often develop PTE?

IMHA creates a hypercoagulable state through several mechanisms — inflammatory cytokines, platelet activation, microvascular thrombosis from hemolysis, and the use of immunosuppressive drugs that contribute to clotting risk. PTE is a major cause of mortality in IMHA dogs, which is why anticoagulation is increasingly part of standard IMHA treatment protocols. The connection is well-documented and drives a lot of current IMHA care guidelines.